
The least requested specializations and the crisis of attractiveness of the public sector
AI-generated summary
Doctors in training must choose a 3-5 year specialization to practice clinically. The public sector suffers from increasing difficulty in recruiting specialized personnel.
The flight of white coats from public healthcare began immediately after graduating in medicine. When young doctors have to decide which specialization to follow - a 3-5 year training course that is inevitable for clinical practice - many snub all those careers that have the public hospital as a professional outlet.
The data - collected by Als Anaao young people for Il Sole 24 Ore - see a clear split linked to the too unattractive earning possibilities in the NHS: among the least chosen specializations - with unassigned places ranging from 50% to 87% - there are those to become microbiologists and virologists (completely out of fashion after Covid), but also pharmacologists, clinical pathologists, radiotherapists, primary or palliative care doctors who work largely in the sector public and as mentioned emergency room doctors. But even the surgeon is losing more and more appeal, perhaps due to the risks of criminal cases and requests for compensation.
Here are the least requested and most popular medical specializations:
A study by the Catholic University undermines the promises of synthetic foods, highlighting high energy consumption, high costs and unknowns regarding health safety. Minister Lollobrigida reiterates the defense of the traditional Italian agri-food model.

An increase in measles cases in Pennsylvania and New York, with unvaccinated patients experiencing serious complications, has prompted authorities to declare an emergency and ramp up administration of MMR vaccines.

On the occasion of World Sight Day, ophthalmologist Domenico Schiano underlines the importance of prevention against blindness and warns of the global increase in myopia, linked above all to a sedentary lifestyle and prolonged use of screens.
The death of a researcher in Irkutsk from severe pneumonia has raised suspicions of a plague-related laboratory accident. Despite Moscow's denials, WHO, USA and EU are calling for transparency on health risks and emergency management.
At the Gemelli Polyclinic in Rome, the first operation in the world on an inoperable pancreatic tumor was performed using a radioactive biological glue, YntraDose, developed by the Italian biotech BetaGlue Therapeutics.

WHO has requested detailed information from Russia on the death of a 28-year-old researcher in Irkutsk, initially suspected of pneumonic plague. Moscow denies epidemic risks and violations, while Mongolia strengthens health controls at the border.